ArticleDrugs in R&D2025

An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate.

Derek E Murrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.